ClinicalTrials.gg
TerminatedNCT00156598Updated Jul 2, 2012

Metal Ion Serum Concentrations in Patients With Total Hip Replacements

An observational study in Osteoarthritis, sponsored by The University of Texas Health Science Center at San Antonio. Terminated. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-07-02.

Sponsored by The University of Texas Health Science Center at San Antonio · Observational

Why this study was terminated
Resident graduated; faculty mentor retired
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
5
Ages
18 Years and older
Sex
All
01

Study summary

Other research studies have shown that the levels of metals in the blood are slightly increased after patients receive a total hip replacement. We want to learn whether these elevated levels are associated with any adverse effects. We hope this study will help us identify which type of patients have elevated levels of metal in their blood.

Read the detailed description

It is suspected that the concentration of the metals chromium, cobalt and titanium in the blood will be higher in people with an all metal total hip prosthesis than in those with a plastic and metal prosthesis. To find out if this is true, we will test blood samples for the levels of metal in the blood and compare the values from 3 groups of people:

  1. people with metal on metal hip replacements
  2. loosening of a plastic and metal prosthesis and
  3. evidence of osteoarthritis and are awaiting a total hip replacement.
02

Conditions studied

  • Osteoarthritis

Browse trials for

Keywords

  • metal ion concentration
03

In context

Osteoarthritis

4,445 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 5 is below the median of 100 across 803 observational studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

The University of Texas Health Science Center at San Antonio is the lead sponsor of 443 studies on the registry; 88 are open to participants now.

Of its 64 completed or terminated interventional studies of FDA-regulated products, 35 (55%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Local surgeon's patients who have had a hip implant.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Group 1 - unilateral hip replacement with metal on metal prosthesis, well functioning.

Group 2 - loosening of plastic and metal prosthesis Group 3 - osteoarthritis of the hip and awaiting total hip replacement

Exclusion criteria

Exclusion Criteria:

  • renal dysfunction
  • other types of metal implants or dental prostheses
  • rheumatoid arthritis
  • hip infection
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
5 participants (actual)
06

Study locations

No study locations are listed for this record.

07

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2004, a primary completion of May 2010 and a completion of May 2010. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 7, 2005
First posted
Sep 12, 2005
Start
Aug 2004
Primary completionActual
May 2010
CompletionActual
May 2010
Last update
Jul 2, 2012
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 2, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00156598
Collaborators
DePuy Orthopaedics
Responsible party
Sponsor
First posted
Sep 12, 2005
Start date
Aug 2004
Primary completion
May 2010
Completion
May 2010
Last update
Jul 2, 2012

Study contacts

Lorence Trick, MD
principal investigator · University of Texas Health Science Center Department of Orthopaedics
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jun 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion